


Antibiotic resistance: Nosopharm and the University of Illinois at Chicago in Molecular Cell

Genoscience Pharma starts first-in-human dosing of GNS561 in patients with advanced liver cancer

Paris Region Entreprises, GIP Resah and Medicen launch call for projects for European ehealth start-ups

NovAliX enters into cooperation agreement with Max-Planck spin-off

Medicen and partners organize 2nd edition of Franco-Québécois Forum for Health Innovation (FFQIS)

Domain’s business model gains validation through Prexton’s acquisition by Lundbeck for up to $1.1 billion

Lundbeck to acquire Prexton Therapeutics in a deal valued at up to €905 million

Sebia launches new-generation serum free light chain (sFLC) assays for multiple myeloma testing
